| Ident. | Authors (with country if any) | Title |
|---|
| 000035 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000078 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000087 (2020) |
Daniel B. Jernigan | Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020. |
| 000165 (2020) |
Shibo Jiang [République populaire de Chine, États-Unis] ; Zheng-Li Shi [République populaire de Chine] | The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus |
| 000196 (2020) |
Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis] | Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses |
| 000315 (2020) |
Yu-Chen Cao [République populaire de Chine] ; Qi-Xin Deng [République populaire de Chine] ; Shi-Xue Dai [République populaire de Chine] | Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence |
| 000380 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000396 (2020) |
Junxiong Pang [Singapour] ; Min Xian Wang [Singapour] ; Ian Yi Han Ang ; Sharon Hui Xuan Tan ; Ruth Frances Lewis ; Jacinta I-Pei Chen ; Ramona A. Gutierrez ; Sylvia Xiao Wei Gwee [Singapour] ; Pearleen Ee Yong Chua [Singapour] ; Qian Yang ; Xian Yi Ng ; Rowena K. S. Yap ; Hao Yi Tan ; Yik Ying Teo ; Chorh Chuan Tan ; Alex R. Cook ; Jason Chin-Huat Yap ; Li Yang Hsu | Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review |
| 000400 (2020) |
Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. |
| 000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
| 000548 (2020) |
Young-Il Kim [Corée du Sud] ; Seong-Gyu Kim [Corée du Sud] ; Se-Mi Kim [Corée du Sud] ; Eun-Ha Kim [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; Kwang-Min Yu [Corée du Sud] ; Jae-Hyung Chang [Corée du Sud] ; Eun Ji Kim [Corée du Sud] ; Seunghun Lee [Corée du Sud] ; Mark Anthony B. Casel [Corée du Sud] ; Jihye Um [Corée du Sud] ; Min-Suk Song [Corée du Sud] ; Hye Won Jeong [Corée du Sud] ; Van Dam Lai [Corée du Sud] ; Yeonjae Kim [Corée du Sud] ; Bum Sik Chin [Corée du Sud] ; Jun-Sun Park [Corée du Sud] ; Ki-Hyun Chung [Corée du Sud] ; Suan-Sin Foo [États-Unis] ; Haryoung Poo [Corée du Sud] ; In-Pil Mo [Corée du Sud] ; Ok-Jun Lee [Corée du Sud] ; Richard J. Webby [États-Unis] ; Jae U. Jung [États-Unis] ; Young Ki Choi [Corée du Sud] | Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. |
| 000564 (2020) |
Ruklanthi De Alwis [Singapour] ; Shiwei Chen [Singapour] ; Esther S. Gan [Singapour] ; Eng Eong Ooi [Singapour] | Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |
| 000682 (2020) |
Naveen Vankadari [Australie] ; Jacqueline A. Wilce [Australie] | Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. |
| 000687 (2020) |
Arshi Islam [Inde] ; Anwar Ahmed [Arabie saoudite] ; Irshad H. Naqvi [Inde] ; Shama Parveen [Inde] | Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020 |
| 000697 (2020) |
Franck Katembo Sikakulya ; Olivier Mulisya ; Dalton Kambale Munyambalu [Ouganda] ; Gabriel Kambale Bunduki | Ebola in the Eastern Democratic Republic of Congo: One Health approach to infectious disease control. |
| 000746 (2020) |
Dae-Gyun Ahn [Corée du Sud] ; Hye-Jin Shin [Corée du Sud] ; Mi-Hwa Kim [Corée du Sud] ; Sunhee Lee [Corée du Sud] ; Hae-Soo Kim [Corée du Sud] ; Jinjong Myoung [Corée du Sud] ; Bum-Tae Kim [Corée du Sud] ; Seong-Jun Kim [Corée du Sud] | Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). |
| 000799 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
| 000903 (2020) |
Balachandar Vellingiri [Inde] ; Kaavya Jayaramayya [Inde] ; Mahalaxmi Iyer [Inde] ; Arul Narayanasamy [Inde] ; Vivekanandhan Govindasamy [Inde] ; Bupesh Giridharan [Inde] ; Singaravelu Ganesan [Inde] ; Anila Venugopal [Inde] ; Dhivya Venkatesan [Inde] ; Harsha Ganesan [Inde] ; Kamarajan Rajagopalan [Inde] ; Pattanathu K S M. Rahman [Royaume-Uni] ; Ssang-Goo Cho [Corée du Sud] ; Nachimuthu Senthil Kumar [Inde] ; Mohana Devi Subramaniam [Inde] | COVID-19: A promising cure for the global panic. |
| 000904 (2020) |
Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande] | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics |
| 000917 (2020) |
Toshiaki Kikuchi | COVID-19 outbreak: an elusive enemy☆ |
| 000931 (2020) |
Deepak Atri [États-Unis] ; Hasan K. Siddiqi [États-Unis] ; Joshua Lang [États-Unis] ; Victor Nauffal [États-Unis] ; David A. Morrow [États-Unis] ; Erin A. Bohula [États-Unis] | COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. |
